North America Neurovascular Devices/Interventional Neurology Market Forecast 2023-2032
KEY FINDINGS
The North America neurovascular devices/interventional neurology market is estimated to rise with a CAGR of 5.39% over the forecasting years of 2023 to 2032. The market growth of the region is attributed to the rising investments in cutting-edge medical technologies, increased access to interventional neurology treatments, and the surge in neurovascular illnesses.
MARKET INSIGHTS
The North America neurovascular devices/interventional neurology market growth analysis entails the study of Canada and the United States. In Canada, the prevalence of age-related neurovascular illnesses, such as strokes, aneurysms, and vascular abnormalities, is on the rise alongside the aging population. According to the 2022 Population Estimates by Age and Sex report from Statistics Canada, 18.8% of the Canadian population is aged above 65 years, making the elderly more vulnerable to neurovascular conditions due to aging-related changes in blood vessels as well as other risk factors.
The Canadian government and regulatory bodies have greatly supported the adoption of cutting-edge medical technologies and healthcare innovation. Aligning with this, favorable efforts and policies have been implemented to promote the use of advanced neurovascular devices and secure funding for research and development. In light of this, Canadian patients have shown a preference for minimally invasive procedures, which offer shorter recovery times and lower risks compared to conventional open surgeries. Subsequently, the growing demand for neurovascular devices that enable less invasive procedures is a direct result of this patient choice. As a result, the aforementioned factors are set to boost the neurovascular devices/interventional neurology market growth in North America over the forecast years.
COMPETITIVE INSIGHTS
The top companies operating in the market are Medtronic Inc, Stryker Corporation, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Methodology
- 1.3. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 2.3. Scope Of Study
- 2.4. Crisis Scenario Analysis
- 2.4.1. Impact Of Covid-19 On Neurovascular Devices/Interventional Neurology Market
- 2.5. Major Market Findings
- 2.5.1. Government Initiatives To Create Awareness About Neurovascular Diseases
- 2.5.2. Early Detection Of Arteriovenous Malformation (Avm)
- 2.5.3. Thrombectomy Improves Patient Outcomes And Reduces Disability Rate
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Significant Rise In Incidence Of Neurovascular Conditions
- 3.1.2. Preference For Minimally Invasive Procedures
- 3.1.3. Geriatric Population’s Vulnerability To Neurovascular Diseases
- 3.1.4. Underlying Diseases Are A Risk Factor For Neurovascular Diseases
- 3.2. Key Restraints
- 3.2.1. Exorbitant Costs Of Neurovascular Devices
- 3.2.2. Lack Of Trained Neurosurgeons
- 4. Key Analytics
- 4.1. Key Market Trends
- 4.2. Porter’s Five Forces Analysis
- 4.2.1. Buyers Power
- 4.2.2. Suppliers Power
- 4.2.3. Substitution
- 4.2.4. New Entrants
- 4.2.5. Industry Rivalry
- 4.3. Growth Prospect Mapping
- 4.3.1. Growth Prospect Mapping For United States
- 4.4. Market Concentration Analysis
- 4.5. Value Chain Analysis
- 5. Market By Product
- 5.1. Embolization Devices
- 5.1.1. Embolic Coils
- 5.1.1.1. Coated Detachable Coils
- 5.1.1.2. Bare Detachable Coils
- 5.1.2. Coil Assist Stent
- 5.1.3. Clippings
- 5.1.4. Coil Assist Balloon
- 5.2. Accessory Devices
- 5.2.1. Microcatheters
- 5.2.2. Micro Guidewires
- 5.3. Revascularization Devices
- 5.3.1. Carotid Artery Stents
- 5.3.2. Flow Diversion Stents
- 5.4. Thrombectomy Devices
- 5.4.1. Clot Retrieval Devices
- 5.4.2. Suction And Aspiration Devices
- 5.4.3. Snares
- 5.5. Embolic Protection Devices
- 5.5.1. Balloon Occlusion Devices
- 5.5.2. Distal Filter Devices
- 6. Market By Application
- 6.1. Aneurysm
- 6.2. Ischemic Stroke
- 6.3. Stenosis
- 6.4. Arteriovenous Malformation (Avm)
- 6.5. Other Applications
- 7. Geographical Analysis
- 7.1. North America
- 7.1.1. Market Size & Estimates
- 7.1.2. North America Neurovascular Devices/Interventional Neurology Market Drivers
- 7.1.3. North America Neurovascular Devices/Interventional Neurology Market Challenges
- 7.1.4. North America Neurovascular Devices/Interventional Neurology Market Regulatory Framework
- 7.1.5. Key Players In North America Neurovascular Devices/Interventional Neurology Market
- 7.1.6. Country Analysis
- 7.1.6.1. United States
- 7.1.6.1.1. United States Neurovascular Devices/Interventional Neurology Market Size & Opportunities
- 7.1.6.2. Canada
- 7.1.6.2.1. Canada Neurovascular Devices/Interventional Neurology Market Size & Opportunities
- 8. Competitive Landscape
- 8.1. Key Strategic Developments
- 8.1.1. Mergers & Acquisitions
- 8.1.2. Product Launches & Developments
- 8.1.3. Partnerships & Agreements
- 8.1.4. Business Expansions & Divestitures
- 8.2. Company Profiles
- 8.2.1. Acandis Gmbh
- 8.2.1.1. Company Overview
- 8.2.1.2. Product List
- 8.2.2. Asahi Intecc
- 8.2.2.1. Company Overview
- 8.2.2.2. Product List
- 8.2.3. Balt
- 8.2.3.1. Company Overview
- 8.2.3.2. Product List
- 8.2.4. B Braun Melsungen Ag
- 8.2.4.1. Company Overview
- 8.2.4.2. Product List
- 8.2.4.3. Strengths & Challenges
- 8.2.5. Integer Holdings Corporation
- 8.2.5.1. Company Overview
- 8.2.5.2. Product List
- 8.2.5.3. Strengths & Challenges
- 8.2.6. Johnson & Johnson (Cerenovus)
- 8.2.6.1. Company Overview
- 8.2.6.2. Product List
- 8.2.6.3. Strengths & Challenges
- 8.2.7. Kaneka Corporation
- 8.2.7.1. Company Overview
- 8.2.7.2. Product List
- 8.2.8. Medtronic Inc
- 8.2.8.1. Company Overview
- 8.2.8.2. Product List
- 8.2.8.3. Strengths & Challenges
- 8.2.9. Memry Corporation
- 8.2.9.1. Company Overview
- 8.2.9.2. Product List
- 8.2.10. Microport Scientific Corporation
- 8.2.10.1. Company Overview
- 8.2.10.2. Product List
- 8.2.10.3. Strengths & Challenges
- 8.2.11. Penumbra Inc
- 8.2.11.1. Company Overview
- 8.2.11.2. Product List
- 8.2.12. Phenox Inc
- 8.2.12.1. Company Overview
- 8.2.12.2. Product List
- 8.2.12.3. Strengths & Challenges
- 8.2.13. Rapid Medical
- 8.2.13.1. Company Overview
- 8.2.13.2. Product List
- 8.2.13.3. Strengths & Challenges
- 8.2.14. Sensome
- 8.2.14.1. Company Overview
- 8.2.14.2. Product List
- 8.2.14.3. Strengths & Challenges
- 8.2.15. Stryker Corporation
- 8.2.15.1. Company Overview
- 8.2.15.2. Product List
- 8.2.15.3. Strengths & Challenges
- 8.2.16. Terumo Corporation
- 8.2.16.1. Company Overview
- 8.2.16.2. Product List
- 8.2.16.3. Strengths & Challenges
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook